Cara Therapeutics (CARA) Insider Trading & Ownership Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Cara Therapeutics (NASDAQ:CARA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.10%Number OfInsiders Buying(Last 3 Years)0Number OfInsiders Selling(Last 3 Years)7Amount OfInsider Selling(Last 3 Years)$563,580.00 Get CARA Insider Trade Alerts Want to know when executives and insiders are buying or selling Cara Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CARA Insider Buying and Selling by Quarter Cara Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/2/2024Christopher PosnerCEOSell109$27.00$2,943.00 4/5/2024Joana GoncalvesInsiderSell76$29.88$2,270.88 2/8/2024Christopher PosnerCEOSell988$19.08$18,851.04 2/8/2024Ryan D MaynardCFOSell152$19.08$2,900.16 2/8/2024Scott TerrillionInsiderSell215$19.08$4,102.20 2/1/2024Christopher PosnerCEOSell138$19.80$2,732.40 11/2/2023Christopher PosnerCEOSell105$43.92$4,611.60 8/3/2023Christopher PosnerCEOSell119$110.52$13,151.88 6/23/2023Frederique Ph.D. MenzaghiSVPSell83$126.36$10,487.88 6/23/2023Scott TerrillionInsiderSell68$126.36$8,592.48 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/5/2023Christopher PosnerCEOSell107$158.40$16,948.80 4/4/2023Frederique Ph.D. MenzaghiSVPSell75$176.76$13,257.00 4/4/2023Scott TerrillionInsiderSell68$176.76$12,019.68 2/2/2023Christopher PosnerCEOSell116$424.80$49,276.80 1/17/2023Joana GoncalvesInsiderSell62$389.16$24,127.92 12/21/2022Frederique Ph.D. MenzaghiSVPSell97$405.72$39,354.84 12/21/2022Joana GoncalvesInsiderSell83$405.72$33,674.76 11/16/2022Christopher PosnerCEOSell401$400.68$160,672.68 9/14/2022Martin VogelbaumDirectorSell300$370.08$111,024.00 7/15/2022Jeffrey L IvesDirectorSell100$325.80$32,580.00 (Data available from 1/1/2013 forward) CARA Insider Trading Activity - Frequently Asked Questions Who is on Cara Therapeutics's Insider Roster? The list of insiders at Cara Therapeutics includes Christopher Posner, Frederique Ph.D. Menzaghi, Jeffrey L Ives, Joana Goncalves, Martin Vogelbaum, Ryan D Maynard, and Scott Terrillion. Learn more on insiders at CARA. What percentage of Cara Therapeutics stock is owned by insiders? 3.10% of Cara Therapeutics stock is owned by insiders. Learn more on CARA's insider holdings. Which Cara Therapeutics insiders have been selling company stock? The following insiders have sold CARA shares in the last 24 months: Christopher Posner ($42,289.92), Frederique Ph.D. Menzaghi ($10,487.88), Joana Goncalves ($2,270.88), Ryan D Maynard ($2,900.16), and Scott Terrillion ($12,694.68). How much insider selling is happening at Cara Therapeutics? Insiders have sold a total of 2,053 Cara Therapeutics shares in the last 24 months for a total of $70,643.52 sold. Cara Therapeutics Key ExecutivesMr. Christopher A. Posner (Age 54)President, CEO & Director Compensation: $1.15MMr. Ryan D. Maynard (Age 55)Chief Financial Officer Compensation: $670.7kDr. Derek T. Chalmers D.Sc. (Age 60)Ph.D., Co-Founder & Senior Advisor Compensation: $580.93kMr. Scott M. Terrillion (Age 61)Chief Compliance Officer, General Counsel & Corporate Secretary Compensation: $689.63kMr. Matthew MurphyManager of Investor Relations More Insider Trading Tools from MarketBeat Related Companies Kyverna Therapeutics Insider Buying OptiNose Insider Buying HilleVax Insider Buying Immunic Insider Buying Zentalis Pharmaceuticals Insider Buying Vaxart Insider Buying Oramed Pharmaceuticals Insider Buying Pliant Therapeutics Insider Buying Cassava Sciences Insider Buying Galectin Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles UnitedHealth Insiders Double Down: Is UNH Stock a Value Play?Sprouts Stock: Insider Sales, But Strong Bullish Signals5 Hot Small-Cap Insiders Bought at the Peak of Tariff FearsThe Top-Ranked Insider Buys From April by Market CapMcDonald’s Insiders Sell Shares! Investors Should Do the Opposite This page (NASDAQ:CARA) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cara Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cara Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CARA Stock Free CARA Stock Alerts